Patent application number | Description | Published |
20080221080 | Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias - The present invention relates to a method of treating a warm-blooded animal, especially a human, having Mixed Lineage Leukemia (MLL rearranged ALL) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially PKC412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of MLL rearranged ALL; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of MLL rearranged ALL. | 09-11-2008 |
20080227800 | Pyrimidylaminobenzamide Derivatives for Hypereosinophilic Syndrome - The present invention relates to the use of pyrimidylaminobenzamide derivatives for the preparation of a drug for the treatment of FIP1L1-PDGFRα-induced or TEL-PDGFRβ-induced myeloproliferative diseases, especially for the curative and/or prophylactic treatment of hypereosinophilic syndrome and hypereosinophilic syndrome with resistance to imatinib, and to a method of treating hypereosinophilic syndrome, chronic eosinophilic leukemia and hypereosinophilic syndrome with resistance to imatinib, or other diseases associated with FIP1L1-PDGFRα, TEL-PDGFRβ or similar mutations that activate PDGFR. | 09-18-2008 |
20100179179 | INHIBITORS OF THE MUTANT FORM OF KIT - The present invention relates to the treatment of KIT dependent diseases that are characterized by a mutant form of KIT whereby the mutant KIT is identified and an appropriate inhibitor of the mutant KIT is administered. | 07-15-2010 |
20100210673 | PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR SYSTEMIC MASTOCYTOSIS - The present invention relates to the use of pyrimidylaminobenzamide derivatives for the preparation of a drug for the treatment of systemic mastocytosis. | 08-19-2010 |
20110009383 | METHOD OF TREATING MIXED LINEAGE LEUKEMIA GENE-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIAS - The present invention relates to a method of treating a warm-blooded animal, especially a human, having Mixed Lineage Leukemia (MLL rearranged ALL) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially PKC412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of MLL rearranged ALL; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of MLL rearranged ALL. | 01-13-2011 |
20120015968 | USE OF PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISORDERS MEDIATED BY THE LEUCINE ZIPPER-AND STERILE ALPHA MOTIF-CONTAINING KINASE (ZAK) - The invention relates to the use of a pyrimidylaminobenzamide derivative of formula I | 01-19-2012 |
20120157441 | INHIBITORS OF THE MUTANT FORM OF KIT - The present invention relates to the treatment of KIT dependent diseases that are characterized by a mutant form of KIT whereby the mutant KIT is identified and an appropriate inhibitor of the mutant KIT selected form midostaurin, vatalanib and compound A is administered. | 06-21-2012 |
20120329779 | Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias - The present invention relates to a method of treating a warm-blooded animal, especially a human, having Mixed Lineage Leukemia (MLL rearranged ALL) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially PKC412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of MLL rearranged ALL; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of MLL rearranged ALL. | 12-27-2012 |
20140057897 | METHOD OF TREATING MIXED LINEAGE LEUKEMIA GENE-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIAS - The present invention relates to a method of treating a warm-blooded animal, especially a human, having Mixed Lineage Leukemia (MLL rearranged ALL) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially PKC412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of MLL rearranged ALL; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of MLL rearranged ALL. | 02-27-2014 |
20140303146 | Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias - The present invention relates to a method of treating a warm-blooded animal, especially a human, having Mixed Lineage Leukemia (MLL rearranged ALL) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially PKC412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of MLL rearranged ALL; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of MLL rearranged ALL. | 10-09-2014 |
Patent application number | Description | Published |
20100131241 | ENTERPRISE WIDE SYSTEM AND METHODS FOR CONFIGURING, DIAGNOSING, AND UPDATING APPLIANCES - A system and methods to provide appliance field support personnel with a tool that, together with proper interface modules, simplifies the execution of diagnostic procedures and provides an easy way to configure, reconfigure, or update electronic boards in the home on a client side of an enterprise wide system. The electronic boards serve as electronic controllers in the appliances and are programmable generic service boards. With such a system, it is possible to update and re-configure electronic boards and interact directly with an electronic controller of an appliance while an appliance is operating. Software, configuration data, and control data are downloaded from a server-side configuration of the enterprise wide system to update the electronic boards. | 05-27-2010 |
20120248879 | Electrical Assembly for Selectively Operating a Household Appliance in a Demonstration Mode or a Standard Mode - An electrical assembly is provided for selectively operating a household appliance in a demonstration mode or a standard mode. A logic unit ( | 10-04-2012 |
20140019530 | ENTERPRISE WIDE SYSTEM AND METHODS FOR CONFIGURING, DIAGNOSING, AND UPDATING APPLIANCES - A system and methods to provide appliance field support personnel with a tool that, together with proper interface modules, simplifies the execution of diagnostic procedures and provides an easy way to configure, reconfigure, or update electronic boards in the home on a client side of an enterprise wide system. The electronic boards serve as electronic controllers in the appliances and are programmable generic service boards. With such a system, it is possible to update and re-configure electronic boards and interact directly with an electronic controller of an appliance while an appliance is operating. Software, configuration data, and control data are downloaded from a server-side configuration of the enterprise wide system to update the electronic boards. | 01-16-2014 |